This Article  • PDF of this Correction  • Original article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on HighWire  • Citing articles on Web of Science (7)  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

JAMA. 2004;291:1070.

Incorrect Table: In the Original Contribution entitled "Efaluzimab for Patients With Moderate to Severe Plaque Psoriasis: A Randomized Controlled Trial" published in the December 17, 2003, issue of THE JOURNAL (2003;290:3073-3080), Table 3 contained erroneous numbers for mean (SD) and median (IQR) placebo group improvement; additionally, erroneous PASI improvement percentage headings were shown. The correct table is shown below.

View this table: [in this window] [in a new window] Table 3. DLQI Improvement Stratified by PASI Response at Week 12

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Psoriasis assessment tools in clinical trials
Feldman and Krueger
Ann Rheum Dis 2005;64:ii65-ii68.
ABSTRACT | FULL TEXT